Meet the Healix Team at IDWeek 2023

Boston, MA

We’re excited to announce that Healix will attend IDWeek 2023 in Boston! This premier infectious disease conference brings together clinicians, researchers, and healthcare professionals to share the latest advancements in patient care and disease prevention.

We would love to connect with you at IDWeek. If you’re interested in learning more about our infusion therapy services or would like to explore potential partnership opportunities with our team, please don’t hesitate to contact us to set up a meeting onsite.  Learn more about our comprehensive service offerings.

We look forward to seeing you at IDWeek 2023!

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.